GREATER DES MOINES, Iowa, Nov. 20, 2024 /PRNewswire/ -- The Greater Des Moines Partnership has announced that its 2025 Annual…
GREATER DES MOINES, Iowa, Nov. 20, 2024 /PRNewswire/ -- The Greater Des Moines Partnership has announced that its 2025 Annual…
November 15, 2024 17:52 ET | Source: Protara Therapeutics NEW YORK, Nov. 15, 2024 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq:…
Presentation to highlight advances in fibrostenotic Crohn’s Disease and the potential of localized PDE4 inhibition Carlsbad, CA, Nov. 14, 2024 (GLOBE…
November 12, 2024 16:30 ET | Source: Psyence Biomedical Ltd. NEW YORK, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Psyence Biomedical…
November 11, 2024 19:14 ET | Source: Pennant Group, Inc. EAGLE, Idaho, Nov. 11, 2024 (GLOBE NEWSWIRE) -- The Pennant…
Novel H2CasMab-2 Antigen Binding Domain Shown to Preferentially Target HER2 Expressed on Tumor Cells in Preclinical Studies Initial Low-Dose Cohort…
November 09, 2024 13:00 ET | Source: Replimune Group Inc Oral presentation highlighting IGNYTE primary analysis data shows anti-tumor activity…
November 09, 2024 10:30 ET | Source: Ultragenyx Pharmaceutical Inc. Phase 1/2 data show improvements across all domains and confirm…
Two oral presentations and multiple posters on clinical andpreclinical-stage candidates to be presented at SITC, demonstratingthe strength of Immatics’ TCR-T…